Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced that ARK Invest has joined ...
Cellares, the world's first Integrated Development and Manufacturing Organization (IDMO) dedicated to automated cell therapy ...
Cellares announced Thursday an agreement with Kite to evaluate its automated manufacturing platform, the Cell Shuttle. NJBIZ has reported on Cellares. Earlier this year, the first Integrated ...
Pharmaceutical Technology on MSN
Cellares and TScan to assess automated manufacturing of TSC-101 therapy
Under the agreement, Cellares will use its Cell Shuttle and Cell Q systems to automate TSC-101 manufacturing processes.
Sony and Cellares announced a joint development collaboration Sept. 12. The two companies say the partnership aims to integrate Sony’s cell-sorting and analytical technologies into the Cell Shuttle, ...
Cellares will automate the TSC-101 manufacturing and testing processes on the Cell Shuttle and the Cell Q automated testing ...
Cellares and ProTgen Partner to Automate Manufacturing for ProT-096, a Novel Progenitor T Cell Therapy Designed to Restore Immune Competence ProT-096 designed to address critical gaps in immune ...
Lyell Immunopharma will evaluate Cellares’ automated manufacturing platform, the Cell Shuttle™, through Cellares’ Technology Adoption Partnership (TAP) program. As part of the collaboration, the ...
Agreement positions Cellares as a long-term commercial manufacturing partner for rese-cel, enabling thousands of batches per year at a cost per batch that is among the lowest in the industry Cellares’ ...
Talk to enough biotech industry folks and the phrase “the product is the process” is bound to come up. It refers to cell therapies, which are made by engineering human cells. In short, the medicine is ...
Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and TScan Therapeutics, Inc. (Nasdaq: TCRX) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results